GILD Gilead Sciences Inc
Performance
0% Past Week
Market Cap
99.77B
Day’s Range
52W Range
Volume (3M)
6.17M
Price-Earnings Ratio
21.98
Revenue
27.09B
Gilead Sciences Inc Latest News
About Gilead Sciences Inc
Gilead Sciences, Inc. is a biopharmaceutical company that focuses on the research, development, and marketing of therapies targeting unmet medical needs and life-threatening conditions. Founded in 1987, the company is headquartered in Foster City, California, and operates in the United States, Europe, and internationally. It trades under the ticker GILD on the NASDAQ. Buy GILD stock to receive updates and information on the GILD price chart.
Show More17K
Employees
Foster City, California, US
HQ
1987
Founded
Daniel P. O'Day, MBA
CEO
Upcoming Earnings
27
APR
REPORTS
Gilead Sciences Inc Q1 2023 earnings report is expected to be released after market open
Consensus
Moderate Buy
Price Target
92.00
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
54
Medium
Industry
Avg. 45
72
Environment
69
Social
37
Governance
People Also Bought
- ELV Elevance Health Inc 2.33%
- CI Cigna Group 1.41%
- BMY Bristol-Myers Squibb Co 1.05%
- BDX Becton Dickinson & Co. 1.74%
- REGN Regeneron Pharmaceuticals 2.27%
79.86